Seda Saka1, Sema Savcı2, Ebru Çalık Kütükcü3, Melda Sağlam3, Naciye Vardar Yağlı3, Deniz İnal İnce3, Meral Boşnak Güçlü4, Özge Özalp3, Hülya Arıkan3, Gül Karakaya5, Lütfi Çöplü5. 1. Department of Physiotherapy and Rehabilitation, Haliç University School of Health Sciences, İstanbul, Turkey. 2. Department of Physiotherapy and Rehabilitation, Dokuz Eylül University School of Health Sciences, İzmir, Turkey. 3. Department of Physiotherapy and Rehabilitation, Hacettepe University School of Health Sciences, Ankara, Turkey. 4. Department of Physiotherapy and Rehabilitation, Gazi University School of Health Sciences, Ankara, Turkey. 5. Department of Chest Medicine, Hacettepe University School of Medicine, Ankara, Turkey.
Abstract
OBJECTIVES: The London Chest Activity of Daily Living Scale (LCADL) is a simple, useful, and comprehensive measure of dyspnea perception in activities of daily living. This study was conducted to determine the validity and reliability of the Turkish version of the LCADL. MATERIALS AND METHODS: A total of 64 patients with obstructive lung disease (24 chronic obstructive pulmonary disease, 20 asthma, and 20 bronchiectasis patients) were included. The Turkish LCADL was evaluated for interobserver reliability, test-retest reliability, and criterion validity. Two different observers applied the scale with an interval of 10 minutes to assess interobserver reliability. The second observer applied the scale twice at an interval of 10-15 days to assess test-retest reliability. Criterion validity was assessed using the 6-minute walk test (6MWT), Nottingham Health Profile (NHP), and Saint George Respiratory Questionnaire (SGRQ). RESULTS: The interobserver reliability of the scale was very high (rs=0.985, p<0.050). Cronbach's alpha coefficient for total score was 0.976 and intraclass correlation coefficient was 0.953. These results indicate that the Turkish LCADL has high reliability. The correlation between LCADL and 6MWT was moderate 0.503 (p=0.002). The LCADL total score was weakly correlated with NHP total score (rs=0.370, p=0.040) and SGRQ total score (rs=0.367, p=0.004). CONCLUSION: The Turkish version of the LCADL scale is reliable and valid in obstructive lung disease. The LCADL scale will be beneficial in existing pulmonary rehabilitation programs aiming to improve functional status. We believe that using the Turkish LCADL scale as an outcome measure in pulmonary rehabilitation programs will serve as an indicator of rehabilitation efficacy for individual patients.
OBJECTIVES: The London Chest Activity of Daily Living Scale (LCADL) is a simple, useful, and comprehensive measure of dyspnea perception in activities of daily living. This study was conducted to determine the validity and reliability of the Turkish version of the LCADL. MATERIALS AND METHODS: A total of 64 patients with obstructive lung disease (24 chronic obstructive pulmonary disease, 20 asthma, and 20 bronchiectasispatients) were included. The Turkish LCADL was evaluated for interobserver reliability, test-retest reliability, and criterion validity. Two different observers applied the scale with an interval of 10 minutes to assess interobserver reliability. The second observer applied the scale twice at an interval of 10-15 days to assess test-retest reliability. Criterion validity was assessed using the 6-minute walk test (6MWT), Nottingham Health Profile (NHP), and Saint George Respiratory Questionnaire (SGRQ). RESULTS: The interobserver reliability of the scale was very high (rs=0.985, p<0.050). Cronbach's alpha coefficient for total score was 0.976 and intraclass correlation coefficient was 0.953. These results indicate that the Turkish LCADL has high reliability. The correlation between LCADL and 6MWT was moderate 0.503 (p=0.002). The LCADL total score was weakly correlated with NHP total score (rs=0.370, p=0.040) and SGRQ total score (rs=0.367, p=0.004). CONCLUSION: The Turkish version of the LCADL scale is reliable and valid in obstructive lung disease. The LCADL scale will be beneficial in existing pulmonary rehabilitation programs aiming to improve functional status. We believe that using the Turkish LCADL scale as an outcome measure in pulmonary rehabilitation programs will serve as an indicator of rehabilitation efficacy for individual patients.
Authors: A E Hesselink; D A W M van der Windt; B W J H Penninx; H A H Wijnhoven; J W R Twisk; L M Bouter; J Th M van Eijk Journal: J Asthma Date: 2006-09 Impact factor: 2.515
Authors: Peter Klijn; Monique Legemaat; Anita Beelen; Anton van Keimpema; Rachel Garrod; Mirella Bergsma; Bill Paterson; Andrew Stuijfzand; Henk van Stel Journal: Medicine (Baltimore) Date: 2015-12 Impact factor: 1.817